Role of the ghrelin/obestatin balance in the regulation of neuroendocrine circuits controlling body composition and energy homeostasis

Molecular and Cellular Endocrinology

Volumn 314, Issue 2, 2010, Pages 244-247

  Epelbaum, Jacques ^a   Bedjaoui, Nawel ^a   Dardennes, Roland ^a   Feng, Dan Dan ^a   Gardette, Robert ^a   Grouselle, Dominique ^a   Loudes, Catherine ^a   Simon, Axelle ^a   Tolle, Virginie ^a   Yang, Seung Kwon ^a   Zizzari, Philippe ^a  

^a INSERM   (France)

Author keywords

Eating disorders; Ghrelin; GHS R1; GPR39; Obestatin

Indexed keywords

BETA ARRESTIN 1; EPIDERMAL GROWTH FACTOR RECEPTOR; G PROTEIN COUPLED RECEPTOR; GHRELIN; GROWTH HORMONE; GROWTH HORMONE SECRETAGOGUE RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE KINASE; OBESTATIN; OLANZAPINE; PROTEIN KINASE B;

ANOREXIA NERVOSA; BINGE EATING DISORDER; BODY COMPOSITION; BULIMIA; COGNITIVE THERAPY; EATING DISORDER; ENERGY METABOLISM; ENZYME PHOSPHORYLATION; FOOD INTAKE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE PHENOTYPE CORRELATION; GROWTH HORMONE RELEASE; HORMONE ACTION; HORMONE RECEPTOR INTERACTION; HUMAN; NONHUMAN; NUTRITIONAL STATUS; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; BODY COMPOSITION; ENERGY METABOLISM; FEEDBACK, PHYSIOLOGICAL; GHRELIN; HUMANS; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, GHRELIN;

EID: 71849117236     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mce.2009.08.026     Document Type: Review

References (46)

1. Alvarez C., Lodeiro M., Theodoropoulou M., Camina J., Casanueva F., and Pazos Y. Obestatin stimulates Akt signalling in gastric cancer cells through {beta}-arrestin-mediated epidermal growth factor receptor transactivation. Endocr. Relat. Cancer (2009) (Epub ahead of print)
2. Ando T., Komaki G., Naruo T., Okabe K., Takii M., Kawai K., Konjiki F., Takei M., Oka T., Takeuchi K., Masuda A., Ozaki N., Suematsu H., Denda K., Kurokawa N., Itakura K., Yamaguchi C., Kono M., Suzuki T., Nakai Y., Nishizono-Maher A., Koide M., Murakami K., Nagamine K., Tomita Y., Ookuma K., Tomita K., Tonai E., Ooshima A., Ishikawa T., and Ichimaru Y. Possible role of preproghrelin gene polymorphisms in susceptibility to bulimia nervosa. Am. J. Med. Genet. B Neuropsychiatr. Genet. 141B December (8) (2006) 929-934
3. Ando T., Ichimaru Y., Konjiki F., Shoji M., and Komaki G. Variations in the preproghrelin gene correlate with higher body mass index, fat mass, and body dissatisfaction in young Japanese women. Am. J. Clin. Nutr. 86 1 (2007) 25-32
4. Bassil A.K., Häglund Y., Brown J., Rudholm T., Hellström P.M., Näslund E., Lee K., and Sanger G.J. Little or no ability of obestatin to interact with ghrelin or modify motility in the rat gastrointestinal tract. Br. J. Pharmacol. 150 1 (2007) 58-64
5. Besser L., Chorin E., Sekler I., Silverman W.F., Atkin S., Russell J.T., and Hershfinkel M. Synaptically released zinc triggers metabotropic signaling via a zinc-sensing receptor in the hippocampus. J. Neurosci. 29 9 (2009) 2890-2901
6. Bluet-Pajot M.T., Tolle V., Zizzari P., Tomasetto C., Grouselle D., and Epelbaum J. Ghrelin, a striking example of neuroendocrine peptide pleiotropy. Med. Sci. (Paris) 21 August-September (8-9) (2005) 715-721
7. Brambilla F., Monteleone P., and Maj M. Olanzapine-induced weight gain in anorexia nervosa, involvement of leptin and ghrelin secretion?. Psychoneuroendocrinology 32 4 (2007) 402-406
8. Bresciani E., Rapetti D., Donà F., Bulgarelli I., Tamiazzo L., Locatelli V., and Torsello A. Obestatin inhibits feeding but does not modulate GH and corticosterone secretion in the rat. Endocrinol. Invest. 29 8 (2006) RC16-RC18
9. Camiña J.P., Campos J.F., Caminos J.E., Dieguez C., and Casanueva F.F. J. Cell Physiol. 213 1 (2007) 187-200
10. Cellini E., Nacmias B., Brecelj-Anderluh M., Badía-Casanovas A., Bellodi L., Boni C., Di Bella D., Estivill X., Fernandez-Aranda F., Foulon C., Friedel S., Gabrovsek M., Gorwood P., Gratacos M., Guelfi J., Hebebrand J., Hinney A., Holliday J., Hu X., Karwautz A., Kipman A., Komel R., Rotella C.M., Ribases M., Ricca V., Romo L., Tomori M., Treasure J., Wagner G., Collier D.A., Sorbi S., Framework E.C.V., and Factors in Healthy Eating Consortium. Case-control and combined family trios analysis of three polymorphisms in the ghrelin gene in European patients with anorexia and bulimia nervosa. Psychiatr. Genet. 16 2 (2006) 51-52
11. Chartrel N., Alvear-Perez R., Leprince J., Iturrioz X., Reaux-Le Goazigo A., Audinot V., Chomarat P., Coge F., Nosjean O., Rodriguez M., Galizzi J.P., Boutin J.A., Vaudry H., and Llorens-Cortes C. Comment on "Obestatin, a peptide encoded by the ghrelin gene, opposes ghrelin's effects on food intake". Science 315 5813 (2007) 766
12. Dardennes R.M., Zizzari P., Tolle V., Foulon C., Kipman A., Romo L., Iancu-Gontard D., Boni C., Sinet P.M., Thérèse Bluet M., Estour B., Mouren M.C., Guelfi J.D., Rouillon F., Gorwood P., and Epelbaum J. Family trios analysis of common polymorphisms in the obestatin/ghrelin, BDNF and AGRP genes in patients with anorexia nervosa, association with subtype, body-mass index, severity and age of onset. Psychoneuroendocrinology 32 2 (2007) 106-113
13. Egerod K.L., Holst B., Petersen P.S., Hansen J.B., Mulder J., Hökfelt T., and Schwartz T.W. GPR39 splice variants versus antisense gene LYPD1, expression and regulation in gastrointestinal tract, endocrine pancreas, liver, and white adipose tissue. Mol. Endocrinol. 21 7 (2007) 1685-1698
14. Feighner S.D., Tan C.P., McKee K.K., Palyha O.C., Hreniuk D.L., Pong S.S., Austin C.P., Figueroa D., MacNeil D., Cascieri M.A., Nargund R., Bakshi R., Abramovitz M., Stocco R., Kargman S., O'Neill G., Van der Ploeg L.H., Evans J., Patchett A.A., Smith R.G., and Howard A.D. Receptor for motilin identified in the human gastrointestinal system. Science 284 (1999) 2184-2188
15. Germain N., Galusca B., Grouselle D., Frere D., Tolle V., Zizzari P., Lang F., Epelbaum J., and Estour B. Ghrelin/obestatin ratio in two populations with low bodyweight. Constitutional thinness and anorexia nervosa. Psychoneuroendocrinology 34 3 (2009) 413-419
16. Gourcerol G., St-Pierre D.H., and Taché Y. Lack of obestatin effects on food intake, should obestatin be renamed ghrelin-associated peptide (GAP)?. Regul. Pept. 141 June (1-3) (2007) 1-7
17. Granata R., Settanni F., Gallo D., Trovato L., Biancone L., Cantaluppi V., Nano R., Annunziata M., Campiglia P., Arnoletti E., Ghè C., Volante M., Papotti M., Muccioli G., and Ghigo E. Obestatin promotes survival of pancreatic beta-cells and human islets and induces expression of genes involved in the regulation of beta-cell mass and function. Diabetes 57 4 (2008) 967-979
18. Hoek H.W. Incidence, prevalence and mortality of anorexia nervosa and other eating disorders. Curr. Opin. Psychiatry 19 4 (2006) 389-394
19. Holst B., Egerod K.L., Schild E., Vickers S.P., Cheetham S., Gerlach L.O., Storjohann L., Stidsen C.E., Jones R., Beck-Sickinger A.G., and Schwartz T.W. GPR39 signaling is stimulated by zinc ions but not by obestatin. Endocrinology 148 (2007) 13-20
20. Howard A.D., Feighner S.D., Cully D.F., Arena J.P., Liberator P.A., Rosenblum C.I., Hamelin M., Hreniuk D.L., Palyha O.C., Anderson J., Paress P.S., Diaz C., Chou M., Liu K.K., McKee K.K., Pong S.S., Chaung L.Y., Elbrecht A., Dashkevicz M., Heavens R., Rigby M., Sirinathsinghji D.J., Dean D.C., Melillo D.G., Patchett A.A., Nargund R., Griffin P.R., DeMartino J.A., Gupta S.K., Schaeffer J.M., Smith R.G., and Van der Ploeg L.H. A receptor in pituitary and hypothalamus that functions in growth hormone release. Science 273 (1996) 974-977
21. Kojima M., Hosoda H., Date Y., Nakazato M., Matsuo H., and Kangawa K. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 402 (1999) 656-660
22. Lagaud G.J., Young A., Acena A., Morton M.F., Barrett T.D., and Shankley N.P. Obestatin reduces food intake and suppresses body weight gain in rodents. Biochem. Biophys. Res. Commun. 357 1 (2007) 264-269
23. Landgren S., Jerlhag E., Zetterberg H., Gonzalez-Quintela A., Campos J., Olofsson U., Nilsson S., Blennow K., and Engel J.A. Association of pro-ghrelin and GHS-R1A gene polymorphisms and haplotypes with heavy alcohol use and body mass. Alcohol Clin. Exp. Res. 32 12 (2008) 2054-2061
24. Lauwers E., Landuyt B., Arckens L., Schoofs L., and Luyten W. Obestatin does not activate orphan G protein-coupled receptor GPR39. Biochem. Biophys. Res. Commun. 351 (2006) 21-25
25. McKee K.K., Tan C.P., Palyha O.C., Liu J., Feighner S.D., Hreniuk D.L., Smith R.G., Howard A.D., and Van der Ploeg L.H. Cloning and characterization of two human G protein-coupled receptor genes (GPR38 and GPR39) related to the growth hormone secretagogue and neurotensin receptors. Genomics 46 (1997) 426-434
26. Miyasaka K., Hosoya H., Sekime A., Ohta M., Amono H., Matsushita S., Suzuki K., Higuchi S., and Funakoshi A. Association of ghrelin receptor gene polymorphism with bulimia nervosa in a Japanese population. J. Neural Transm. 113 9 (2006) 1279-1285
27. Monteleone P., Tortorella A., Castaldo E., Di Filippo C., and Maj M. No association of the Arg51Gln and Leu72Met polymorphisms of the ghrelin gene with anorexia nervosa or bulimia nervosa. Neurosci. Lett. 398 3 (2006) 325-327
28. Monteleone P., Tortorella A., Castaldo E., Di Filippo C., and Maj M. The Leu72Met polymorphism of the ghrelin gene is significantly associated with binge eating disorder. Psychiatr. Genet. 17 1 (2007) 13-16
29. Monteleone P., Serritella C., Martiadis V., and Maj M. Deranged secretion of ghrelin and obestatin in the cephalic phase of vagal stimulation in women with anorexia nervosa. Biol. Psychiatry 64 December (11) (2008) 1005-1008
30. Monteleone P., Serritella C., Martiadis V., Scognamiglio P., and Maj M. Plasma obestatin, ghrelin, and ghrelin/obestatin ratio are increased in underweight patients with anorexia nervosa but not in symptomatic patients with bulimia nervosa. J. Clin. Endocrinol. Metab. 93 November (11) (2008) 4418-4421
31. Nogueiras R., Pfluger P., Tovar S., Arnold M., Mitchell S., Morris A., Perez-Tilve D., Vázquez M.J., Wiedmer P., Castañeda T.R., DiMarchi R., Tschöp M., Schurmann A., Joost H.G., Williams L.M., Langhans W., and Diéguez C. Effects of obestatin on energy balance and growth hormone secretion in rodents. Endocrinology 148 1 (2007) 21-26
32. Otto B., Cuntz U., Fruehauf E., Wawarta R., Folwaczny C., Riepl R.L., Heiman M.L., Lehnert P., Fichter M., and Tschöp M. Weight gain decreases elevated plasma ghrelin concentrations of patients with anorexia nervosa. Eur. J. Endocrinol. 145 5 (2001) 669-673
33. Ramoz N., Versini A., and Gorwood P. Eating disorders, an overview of treatment responses and the potential impact of vulnerability genes and endophenotypes. Expert Opin. Pharmacother. 8 13 (2007) 2029-2044
34. Seoane L.M., Al-Massadi O., Pazos Y., Pagotto U., and Casanueva F.F. Central obestatin administration does not modify either spontaneous or ghrelin-induced food intake in both ad libitum and food restricted rats. J. Endocrinol. Invest. 29 8 (2006) RC13-RC15
35. Sullivan P.F. Mortality in anorexia nervosa. Am. J. Psychiatry 152 7 (1995) 1073-1074
36. Tanaka M., Nakahara T., Kojima S., Nakano T., Muranaga T., Nagai N., Ueno H., Nakazato M., Nozoe S., and Naruo T. Effect of nutritional rehabilitation on circulating ghrelin and growth hormone levels in patients with anorexia nervosa. Regul. Pept. 122 November (3) (2004) 163-168
37. Tolle V., Kadem M., Bluet-Pajot M.T., Frere D., Foulon C., Bossu C., Dardennes R., Mounier C., Zizzari P., Lang F., Epelbaum J., and Estour B. Balance in ghrelin and leptin plasma levels in anorexia nervosa patients and constitutionally thin women. J. Clin. Endocrinol. Metab. 88 1 (2003) 109-116
38. Tozzi F., Thornton L.M., Klump K.L., Fichter M.M., Halmi K.A., Kaplan A.S., Strober M., Woodside D.B., Crow S., Mitchell J., Rotondo A., Mauri M., Cassano G., Keel P., Plotnicov K.H., Pollice C., Lilenfeld L.R., Berrettini W.H., Bulik C.M., and Kaye W.H. Symptom fluctuation in eating disorders, correlates of diagnostic crossover. Am. J. Psychiatry 162 4 (2005) 732-740
39. Tremblay F., Perreault M., Klaman L.D., Tobin J.F., Smith E., and Gimeno R.E. 2 Normal food intake and body weight in mice lacking the G protein-coupled receptor GPR39. Endocrinology 148 (2007) 501-506
40. Wren A.M., Seal L.J., Cohen M.A., Brynes A.E., Frost G.S., Murphy K.G., Dhillo W.S., Ghatei M.A., and Bloom S.R. Ghrelin enhances appetite and increases food intake in humans. J. Clin. Endocrinol. Metab. 86 12 (2001) 5992
41. Yamamoto D., Ikeshita N., Daito R., Herningtyas E.H., Toda K., Takahashi K., Iida K., Takahashi Y., Kaji H., Chihara K., and Okimura Y. Neither intravenous nor intracerebroventricular administration of obestatin affects the secretion of GH, PRL, TSH and ACTH in rats. Regul. Pept. 138 February (2-3) (2007) 141-144
42. Yang J., Brown M.S., Liang G., Grishin N.V., and Goldstein J.L. Identification of the acyltransferase that octanoylates ghrelin, an appetite-stimulating peptide hormone. Cell 132 3 (2008) 387-396
43. 2+ as an endogenous agonist of GPR39 from fetal bovine serum. J. Recept. Signal Transduct. Res. 27 4 (2007) 235-246
44. Zhang J.V., Ren P.G., Avsian-Kretchmer O., Luo C.W., Rauch R., Klein C., and Hsueh A.J. Obestatin, a peptide encoded by the ghrelin gene, opposes ghrelin's effects on food intake. Science 310 5750 (2005) 996-999
45. Zhang J.V., Klein C., Ren P.-G., Kass S., Ver Donck L., Moechars D., and Hsueh A.J.W. Response to comment on "Obestatin, a peptide encoded by the ghrelin gene, opposes ghrelin's effects on food intake. Science 315 (2007) 766
46. Zizzari P., Longchamps R., Epelbaum J., and Bluet-Pajot M.T. Obestatin partially affects ghrelin stimulation of food intake and growth hormone secretion in rodents. Endocrinology 148 (2007) 1648-1653